![](/img/cover-not-exists.png)
Preclinical characterization of BET family bromodomain inhibitor ABBV-075 suggests combination therapeutic strategies
Bui, Mai H., Lin, Xiaoyu, Albert, Daniel H., Li, Leiming, Lam, Lloyd T, Faivre, Emily J., Warder, Scott, Huang, Xiaoli, Wilcox, Denise, Donawho, Cherrie K., Sheppard, George S, Wang, Le, Fidanze, StevLanguage:
english
Journal:
Cancer Research
DOI:
10.1158/0008-5472.CAN-16-1793
Date:
April, 2017
File:
PDF, 4.92 MB
english, 2017